2006
beta-Glucuronidase is an optimal normalization control gene for molecular monitoring of chronic myelogenous leukemia. J Mol Diagn. 2006;8(3):385-9.
Unusual variants of malignant melanoma. Mod Pathol. 2006;19 Suppl 2:S41-70.
Unusual histologic and clinical variants of melanoma: implications for therapy. Curr Treat Options Oncol. 2006;7(3):169-80.
Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses. Am J Obstet Gynecol. 2006;194(1):182-8.
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. J Clin Invest. 2006;116(12):3171-82.
CD8+ lymphomatoid papulosis and its differential diagnosis. Am J Clin Pathol. 2006;125(4):490-501.
Pathology of B-cell non-Hodgkin's lymphomas and multiple myeloma. Cancer Treat Res. 2006;131:1-48.
Subclinical chronic lymphocytic leukaemia associated with a 13q deletion presenting initially in the skin: apropos of a case. J Cutan Pathol. 2006;33(3):256-9.